文献速递肝病

新型蛋白质组特征或可提示MRI评估的肝内脂肪状态及变化:DIRECT PLUS临床试验

Novel proteomic signatures may indicate MRI-assessed intrahepatic fat state and changes: The DIRECT PLUS clinical trial.
PubMed 文献 · Hepatology · 2024-03-27

在18个月随机DIRECT PLUS试验(n=294)中,富含多酚的绿色地中海饮食较其他健康饮食显著减少肝内脂肪百分比(IHF%)。本研究检测95种蛋白质组生物标志物,发现39种蛋白质与基线IHF%显著相关,18种蛋白质变化与IHF%变化显著相关,提示新型蛋白质组特征或可指示MRI评估的肝内脂肪状态及变化。

要点

  • 基线39种候选蛋白与IHF%显著相关(错误发现率<0.05),多与免疫功能通路相关。
  • 18个月生活方式干预引起39种候选蛋白中18种变化,与IHF%变化显著相关。
  • 绿色地中海饮食组血栓反应蛋白-2变化高于地中海饮食组(p=0.01),独立于体重和IHF%减少。

核心结论

  • 研究提示新型蛋白质组特征或可指示MRI评估的肝内脂肪状态及生活方式干预中的变化。
  • 碳酸酐酶5A、羟基酸氧化酶1和血栓反应蛋白-2的蛋白质变化与IHF%变化独立相关。
  • 血栓反应蛋白-2变化在绿色地中海饮食/高多酚饮食组更大。

研究设计与样本

  • 随机18个月DIRECT PLUS试验(n=294),计算IHF%(正常<5%,异常≥5%),检测基线和18个月95种蛋白质组生物标志物。
  • 参与者年龄51.3±10.8岁,89%为男性,体重指数31.3±3.9 kg/m²;18个月保留率89.8%,83%有合格随访蛋白质组测量,78%有随访质子磁共振波谱。

主要发现

  • 基线39种候选蛋白与IHF%显著相关(错误发现率<0.05),多与免疫功能通路相关(如羟基酸氧化酶1)。
  • 基于DIRECT PLUS联合模型的IHF%预测(R²=0.47,均方根误差=1.05)在测试中成功预测IHF%(R²=0.53),优于单独输入蛋白质/传统标志物(R²=0.43/0.44)。
  • 18个月生活方式干预引起39种候选蛋白中18种变化,与IHF%变化显著相关,涉及代谢、细胞外基质重塑和免疫功能通路。
  • 绿色地中海饮食组血栓反应蛋白-2变化高于地中海饮食组(p=0.01),独立于体重和IHF%减少。
  • 蛋白质主成分分析显示第三主成分时间与异常/正常IHF%轨迹组合间存在交互作用(p<0.05)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: We demonstrated in the randomized 18-month DIRECT PLUS trial (n = 294) that a Mediterranean (MED) diet, supplemented with polyphenol-rich Mankai duckweed, green tea, and walnuts and restricted in red/processed meat, caused substantial intrahepatic fat (IHF%) loss compared with 2 other healthy diets, reducing NAFLD by half, regardless of similar weight loss. Here, we investigated the baseline proteomic profile associated with IHF% and the changes in proteomics associated with IHF% changes induced by lifestyle intervention. APPROACH AND RESULTS: We calculated IHF% by proton magnetic resonance spectroscopy (normal IHF% <5% and abnormal IHF% ≥5%). We assayed baseline and 18-month samples for 95 proteomic biomarkers.Participants (age = 51.3 ± 10.8 y; 89% men; and body mass index = 31.3 ± 3.9 kg/m 2 ) had an 89.8% 18-month retention rate; 83% had eligible follow-up proteomics measurements, and 78% had follow-up proton magnetic resonance spectroscopy. At baseline, 39 candidate proteins were significantly associated with IHF% (false discovery rate <0.05), mostly related to immune function pathways (eg, hydroxyacid oxidase 1). An IHF% prediction based on the DIRECT PLUS by combined model ( R2 = 0.47, root mean square error = 1.05) successfully predicted IHF% ( R2 = 0.53) during testing and was stronger than separately inputting proteins/traditional markers ( R2 = 0.43/0.44). The 18-month lifestyle intervention induced changes in 18 of the 39 candidate proteins, which were significantly associated with IHF% change, with proteins related to metabolism, extracellular matrix remodeling, and immune function pathways. Thrombospondin-2 protein change was higher in the green-MED compared to the MED group, beyond weight and IHF% loss ( p = 0.01). Protein principal component analysis revealed differences in the third principal component time distinct interactions across abnormal/normal IHF% trajectory combinations; p < 0.05 for all). CONCLUSIONS: Our findings suggest novel proteomic signatures that may indicate MRI-assessed IHF state and changes during lifestyle intervention. Specifically, carbonic anhydrase 5A, hydroxyacid oxidase 1, and thrombospondin-2 protein changes are independently associated with IHF% change, and thrombospondin-2 protein change is greater in the green-MED/high polyphenols diet.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Goldberg DT, Yaskolka Meir A, Tsaban G, et al. Novel proteomic signatures may indicate MRI-assessed intrahepatic fat state and changes: The DIRECT PLUS clinical trial. Hepatology. 2024. PMID: 38537153. doi:10.1097/HEP.0000000000000867

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。